Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired US-based start-up company Analytical Informatics, Inc., complementing its own innovation initiatives to expand its current offerings and accelerate the roadmap for Philips Radiology Solutions. Analytical Informatics’ products and capabilities, which include vendor-agnostic, advanced workflow tools and applications, strengthen Philips’ PerformanceBridge portfolio of operational performance solutions to optimize assets, uptime, utilization, practice, compliance and staff at the imaging department and enterprise levels. Financial details of the acquisition were not disclosed. “Integrating Analytical Informatics’ software tools and applications into our current offerings will enable us to accelerate the delivery of next-generation technology, software and services, to bring the power of operational intelligence and decision support to radiology,” said Sham Sokka, General Manager of Radiology Solutions at Philips. “We’ll be in an even stronger position to provide our customers with a host of solutions and help them maximize opportunities to do more with less, while delivering patient-centric care.” Analytical Informatics was founded in 2011 as a University of Maryland, Baltimore start-up, when the company licensed technology from the University of Maryland School of Medicine. PerformanceBridge is a flexible portfolio of operational performance improvement solutions that support healthcare providers through a combination of technology, analytics, and on-site and professional services. The goal of PerformanceBridge is to enable imaging departments to make informed decisions to enhance performance, address gaps, monitor progress and drive continuous improvement. One specific offering within this portfolio is PerformanceBridge Practice, which has been designed to help imaging departments simplify and unify various levels of data and unlock actionable information to enhance operational and clinical decision making that’s centered around the patient. This comprehensive, data-driven practice management solution leverages Philips' integrated suite of digital health technology capabilities, and is where Analytical Informatics' vendor-agnostic, application-based, business analytics software will be integrated, enabling further customization of Philips' intelligence tooling and data analytics. In addition to the integration of Analytical Informatics’ advanced workflow tools and applications into PerformanceBridge Practice, the PerformanceBridge portfolio is being expanded with the following features: For more information on Philips’ complete portfolio of integrated imaging systems, devices, informatics and services, please visit the Philips booth (#6735) during the 2017 Radiological Society of North America Annual Meeting (RSNA), November 26 through December 1 at McCormick Place in Chicago. For live updates from the event, please follow @PhilipsLiveFrom or visit www.philips.com/rsna. * Work in progress and not available for sale.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
Philips Global Press Office Tel: +31 6 10888824
You are about to visit a Philips global content page
ContinueYou are about to visit the Philips USA website.
I understand Philips Investor Relations Tel: +31 20 59 77055
You are about to visit a Philips global content page
ContinueYou are about to visit the Philips USA website.
I understandGet our press releases by e-mail
You are about to visit a Philips global content page
ContinueYou are about to visit the Philips USA website.
I understandYou are about to visit a Philips global content page
ContinueYou are about to visit the Philips USA website.
I understand